A low cost and portable smartphone integrated system could improve infectious disease treatment and allow for better surveillance.
The biotechnology company, AYOXXA Biosystems, have launched a low-volume beads-on-a-chip multiplex protein analysis system termed LUNARIS™. It is aimed to quantify soluble inflammation and immune response markers.
Researchers from the University of Malaya (Kuala Lumpur, Malaysia) have developed a new electrochemical immunosensor that can quantify concentrations of biotin in serum.
Researchers from the University of Texas (TX, USA) have developed a wearable device that can rapidly and reliably monitor three interconnected compounds associated with Type 2 diabetes for as long as a week.
A collaborative team of researchers from Illinois (Il, USA) have developed a device that can rapidly and reliably diagnosis sepsis.
Thermo Fisher Scientific Inc. (MA, USA) have announced new technologies that obtain high-resolution separations with increased sensitivity and reproducibility.
View some of the poster presentations delivered at this years 11th WRIB conference.
The CRO BioPharmaSpec, have announced plans to increase in-house capabilities, including the 3D structure characterization of proteins.
A post analysis study has revealed that 17% of patients from a recent heart failure clinical trial were ineligible, prompting major concerns over the integrity of some international clinical trials.
MilliporeSigma (Billerica, MA, USA) has announced the launch of their new Single Molecule Counting Platform that could aid drug discovery and development.